EGR1, FOS, MYC and YY1 all showed a large number of binding sites around miR-576, and these frequently overlapped with histone modifications which mark active promoter and enhancer regions, consistent with these four transcription factors driving gene expression signatures in FSHD. The gene discussed is MYC; the disease is facioscapulohumeral muscular dystrophy.